Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3b/4 clinical study ...

The pooled odds ratio (OR) was 1.27, indicating a statistically significant association between atopic dermatitis and stroke.

Dupixent shows potential as a treatment for atopic dermatitis, alopecia and vitiligo, targeting shared immune pathways for ...

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that significantly impacts quality of life and often ...

Nektar Therapeutics is fairly valued based on rNPV modeling, but multiple near-term catalysts could drive upside. Learn why ...

With sales of atopic dermatitis (AD) treatment Adbry scaling up in the U.S., Leo Pharma is accomplishing one of the goals established by CEO Christophe Bourdon when he took over at the Danish ...

Discover a study showing how online clustered nursing care improves symptoms and enhances sleep quality in adults with atopic dermatitis.

Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.

For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

Because infection can sometimes cause atopic dermatitis, agents that kill the bacteria or virus that’s causing the issue may be issued by a doctor in extreme situations.